Skip to content

PAVmed Inc.

PAVM

CIK 0001624326

← back to feed
Revenue (TTM)
$41K
−97.6% YoY Q1 May 2026
Net Income (TTM)
$1.6M
−99.0% YoY Q1 May 2026
EPS Diluted (TTM)
$4.65
−137.8% YoY Q1 May 2026
Gross Margin
-207.3%
Q1 May 2026
Operating Margin
-56,195.1%
Q1 May 2026
Net Margin
3,912.2%
Q1 May 2026
Free Cash Flow (TTM)
−$33.77M
Q1 May 2026
Cash
$6.46M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
7.27M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings